These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 8080443)

  • 1. Comparative study of intracellular calcium and adenosine 3',5'-cyclic monophosphate levels in human breast carcinoma cells sensitive or resistant to Adriamycin: contribution to reversion of chemoresistance.
    Mestdagh N; Vandewalle B; Hornez L; Hénichart JP
    Biochem Pharmacol; 1994 Aug; 48(4):709-16. PubMed ID: 8080443
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Contribution of glutathione and glutathione-dependent enzymes in the reversal of adriamycin resistance in colon carcinoma cell lines.
    Lai GM; Moscow JA; Alvarez MG; Fojo AT; Bates SE
    Int J Cancer; 1991 Nov; 49(5):688-95. PubMed ID: 1682279
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Reversal of resistance to adriamycin by 8-chloro-cyclic AMP in adriamycin-resistant HL-60 leukemia cells is associated with reduction of type I cyclic AMP-dependent protein kinase and cyclic AMP response element-binding protein DNA-binding activities.
    Rohlff C; Safa B; Rahman A; Cho-Chung YS; Klecker RW; Glazer RI
    Mol Pharmacol; 1993 Mar; 43(3):372-9. PubMed ID: 8383802
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of various chemosensitizers on chemoresistance to adriamycin in MIP-101 cell line, a colon carcinoma cell line: analysis of glutathione and related enzymes.
    Mestdagh N; Morier-Teissier E; Hénichart JP
    Anticancer Drugs; 1993 Dec; 4(6):641-50. PubMed ID: 7905301
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Glutathione depletion in human and in rat multi-drug resistant breast cancer cell lines.
    Batist G; Schecter R; Woo A; Greene D; Lehnert S
    Biochem Pharmacol; 1991 Feb; 41(4):631-5. PubMed ID: 1997009
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of the MDR-1-encoded multiple drug resistance phenotype in prostate cancer cell lines.
    Theyer G; Schirmböck M; Thalhammer T; Sherwood ER; Baumgartner G; Hamilton G
    J Urol; 1993 Nov; 150(5 Pt 1):1544-7. PubMed ID: 8105110
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Changes in subcellular doxorubicin distribution and cellular accumulation alone can largely account for doxorubicin resistance in SW-1573 lung cancer and MCF-7 breast cancer multidrug resistant tumour cells.
    Schuurhuis GJ; van Heijningen TH; Cervantes A; Pinedo HM; de Lange JH; Keizer HG; Broxterman HJ; Baak JP; Lankelma J
    Br J Cancer; 1993 Nov; 68(5):898-908. PubMed ID: 8105865
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of buthionine sulfoximine on toxicity of verapamil and doxorubicin to multidrug resistant cells and to mice.
    Ford JM; Yang JM; Hait WN
    Cancer Res; 1991 Jan; 51(1):67-72. PubMed ID: 1988108
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chemoresistance in breast tumors.
    Giai M; Biglia N; Sismondi P
    Eur J Gynaecol Oncol; 1991; 12(5):359-73. PubMed ID: 1680689
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Membrane potential differences between adriamycin-sensitive and -resistant cells as measured by flow cytometry.
    Hasmann M; Valet GK; Tapiero H; Trevorrow K; Lampidis T
    Biochem Pharmacol; 1989 Jan; 38(2):305-12. PubMed ID: 2914014
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Complete reversal by thaliblastine of 490-fold adriamycin resistance in multidrug-resistant (MDR) human breast cancer cells. Evidence that multiple biochemical changes in MDR cells need not correspond to multiple functional determinants for drug resistance.
    Chen G; Waxman DJ
    J Pharmacol Exp Ther; 1995 Sep; 274(3):1271-7. PubMed ID: 7562498
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mechanisms and modulation of multidrug resistance in primary human renal cell carcinoma.
    Mickisch GH; Roehrich K; Koessig J; Forster S; Tschada RK; Alken PM
    J Urol; 1990 Sep; 144(3):755-9. PubMed ID: 1974934
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lack of glutathione conjugation to adriamycin in human breast cancer MCF-7/DOX cells. Inhibition of glutathione S-transferase p1-1 by glutathione conjugates from anthracyclines.
    Gaudiano G; Koch TH; Lo Bello M; Nuccetelli M; Ravagnan G; Serafino A; Sinibaldi-Vallebona P
    Biochem Pharmacol; 2000 Dec; 60(12):1915-23. PubMed ID: 11108808
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Partial reversal of doxorubicin resistance by forskolin and 1,9-dideoxyforskolin in murine sarcoma S180 variants.
    Wadler S; Wiernik PH
    Cancer Res; 1988 Feb; 48(3):539-43. PubMed ID: 2825978
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reduced intracellular drug accumulation in the absence of P-glycoprotein (mdr1) overexpression in mitoxantrone-resistant human MCF-7 breast cancer cells.
    Nakagawa M; Schneider E; Dixon KH; Horton J; Kelley K; Morrow C; Cowan KH
    Cancer Res; 1992 Nov; 52(22):6175-81. PubMed ID: 1358431
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of calcium antagonists on the chemosensitivity of two multidrug-resistant human tumour cell lines which do not overexpress P-glycoprotein.
    Cole SP; Downes HF; Slovak ML
    Br J Cancer; 1989 Jan; 59(1):42-6. PubMed ID: 2569325
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Relationship between expression of P-glycoprotein and efficacy of trifluoperazine in multidrug-resistant cells.
    Ganapathi R; Kuo T; Teeter L; Grabowski D; Ford J
    Mol Pharmacol; 1991 Jan; 39(1):1-8. PubMed ID: 1670962
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cellular and biochemical characterization of thioxanthenes for reversal of multidrug resistance in human and murine cell lines.
    Ford JM; Bruggemann EP; Pastan I; Gottesman MM; Hait WN
    Cancer Res; 1990 Mar; 50(6):1748-56. PubMed ID: 1968358
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of the efficacy of a phenothiazine and a bisquinaldinium calmodulin antagonist against multidrug-resistant P388 cell lines.
    Hait WN; Pierson NR
    Cancer Res; 1990 Feb; 50(4):1165-9. PubMed ID: 2297765
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Experimental models for the study of drug resistance in osteosarcoma: P-glycoprotein-positive, murine osteosarcoma cell lines.
    Takeshita H; Gebhardt MC; Springfield DS; Kusuzaki K; Mankin HJ
    J Bone Joint Surg Am; 1996 Mar; 78(3):366-75. PubMed ID: 8613443
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.